Exercise Intervention Study for Early-Stage Breast Cancer Patients Receiving Neoadjuvant Therapy.

Clinical Trial ID NCT00405678

PubWeight™ 0.97‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00405678

Top papers

Rank Title Journal Year PubWeight™‹?›
1 New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000 133.74
2 Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004 49.02
3 Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997 30.27
4 Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 2005 23.44
5 Hypoxia--a key regulatory factor in tumour growth. Nat Rev Cancer 2002 20.51
6 Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 2002 14.30
7 A simple method to assess exercise behavior in the community. Can J Appl Sport Sci 1985 13.27
8 Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy. Nat Med 2001 10.37
9 Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999 10.16
10 Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases. Cancer Cell 2004 8.78
11 Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument. J Clin Oncol 1997 7.79
12 Influences of cardiorespiratory fitness and other precursors on cardiovascular disease and all-cause mortality in men and women. JAMA 1996 7.45
13 Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A 2000 6.59
14 Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors. Cancer Res 2004 5.65
15 Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer. J Clin Oncol 2001 5.31
16 Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer. J Clin Oncol 2005 5.27
17 Effect of exercise on coronary endothelial function in patients with coronary artery disease. N Engl J Med 2000 4.43
18 Addition of bevacizumab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: results of a randomized phase II trial. J Clin Oncol 2005 4.32
19 HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest 2001 4.11
20 Regular physical activity improves endothelial function in patients with coronary artery disease by increasing phosphorylation of endothelial nitric oxide synthase. Circulation 2003 3.86
21 Pathology: cancer cells compress intratumour vessels. Nature 2004 3.60
22 Randomized controlled trial of exercise training in postmenopausal breast cancer survivors: cardiopulmonary and quality of life outcomes. J Clin Oncol 2003 3.56
23 Effect of exercise training on endothelium-derived nitric oxide function in humans. J Physiol 2004 3.48
24 Tumour biology: herceptin acts as an anti-angiogenic cocktail. Nature 2002 3.40
25 Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. J Clin Oncol 2003 3.07
26 Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest 2000 2.96
27 Assessment of leisure time exercise behavior by self-report: a concurrent validity study. Can J Public Health 1987 2.94
28 Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure. Circulation 1998 2.90
29 The Functional Assessment of Cancer Therapy-Anemia (FACT-An) Scale: a new tool for the assessment of outcomes in cancer anemia and fatigue. Semin Hematol 1997 2.68
30 Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation 2003 2.59
31 Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer. Clin Cancer Res 2002 2.57
32 Bone marrow-derived endothelial progenitor cells participate in cerebral neovascularization after focal cerebral ischemia in the adult mouse. Circ Res 2002 2.45
33 HMG-CoA reductase inhibitor mobilizes bone marrow--derived endothelial progenitor cells. J Clin Invest 2001 2.20
34 Structured exercise improves physical functioning in women with stages I and II breast cancer: results of a randomized controlled trial. J Clin Oncol 2001 2.16
35 Differential prognostic impact of hypoxia induced and diffuse HIF-1alpha expression in invasive breast cancer. J Clin Pathol 2005 2.10
36 Fundamentals of endothelial function for the clinical cardiologist. Circulation 2002 2.07
37 Limited penetration of anticancer drugs through tumor tissue: a potential cause of resistance of solid tumors to chemotherapy. Clin Cancer Res 2002 2.05
38 Effects of an oncologist's recommendation to exercise on self-reported exercise behavior in newly diagnosed breast cancer survivors: a single-blind, randomized controlled trial. Ann Behav Med 2004 2.04
39 Hypoxia-inducible factors HIF-1alpha and HIF-2alpha in head and neck cancer: relationship to tumor biology and treatment outcome in surgically resected patients. Cancer Res 2002 1.84
40 Remodeling of the extracellular matrix through overexpression of collagen VI contributes to cisplatin resistance in ovarian cancer cells. Cancer Cell 2003 1.81
41 Polychemotherapy for early breast cancer: an overview of the randomised clinical trials with quality-adjusted survival analysis. Lancet 2001 1.79
42 Hypoxia-mediated down-regulation of Bid and Bax in tumors occurs via hypoxia-inducible factor 1-dependent and -independent mechanisms and contributes to drug resistance. Mol Cell Biol 2004 1.77
43 Cathepsin L is required for endothelial progenitor cell-induced neovascularization. Nat Med 2005 1.69
44 A systems approach to cancer therapy. (Antioncogenics + standard cytotoxics-->mechanism(s) of interaction). Cancer Metastasis Rev 1996 1.68
45 Hypoxia increases resistance of human pancreatic cancer cells to apoptosis induced by gemcitabine. Clin Cancer Res 2004 1.68
46 Changes in vegetable and fruit consumption and awareness among US adults: results of the 1991 and 1997 5 A Day for Better Health Program surveys. J Am Diet Assoc 2002 1.67
47 Improving chemotherapeutic drug penetration in tumors by vascular targeting and barrier alteration. J Clin Invest 2002 1.67
48 Exercise counseling and programming preferences of cancer survivors. Cancer Pract 2002 1.59
49 Exercise acutely increases circulating endothelial progenitor cells and monocyte-/macrophage-derived angiogenic cells. J Am Coll Cardiol 2004 1.50
50 Increase of circulating endothelial progenitor cells in patients with coronary artery disease after exercise-induced ischemia. Arterioscler Thromb Vasc Biol 2004 1.45
51 Design of FRESH START: a randomized trial of exercise and diet among cancer survivors. Med Sci Sports Exerc 2003 1.40
52 Transplanted human bone marrow contributes to vascular endothelium. Proc Natl Acad Sci U S A 2004 1.39
53 Nitric oxide-mediated metabolic regulation during exercise: effects of training in health and cardiovascular disease. FASEB J 2000 1.33
54 Leading the Way in Exercise and Diet (Project LEAD): intervening to improve function among older breast and prostate cancer survivors. Control Clin Trials 2003 1.29
55 Tumor physiology and drug resistance. Cancer Metastasis Rev 2001 1.23
56 Clinical aspects of drug delivery to tumors. J Control Release 2002 1.20
57 Time course of improved flow-mediated dilation after short-term exercise training. Med Sci Sports Exerc 2003 1.15
58 Hypoxia-inducible factor 1 alpha in high-risk breast cancer: an independent prognostic parameter? Breast Cancer Res 2004 1.14
59 Regional and whole-body markers of nitric oxide production following hyperemic stimuli. Free Radic Biol Med 2005 1.13
60 Systemic therapy for treating locoregional recurrence in women with breast cancer. Cochrane Database Syst Rev 2001 1.10
61 Effects of exercise training on antitumor efficacy of doxorubicin in MDA-MB-231 breast cancer xenografts. Clin Cancer Res 2005 1.09
62 Effect of exercise training on endothelial function in men with coronary artery disease. Am J Cardiol 2004 1.07
63 Exercise training improves conduit vessel function in patients with coronary artery disease. J Appl Physiol (1985) 2003 1.06
64 Exercise discussions during cancer treatment consultations. Cancer Pract 2002 1.05
65 Chemotherapy alone versus endocrine therapy alone for metastatic breast cancer. Cochrane Database Syst Rev 2003 1.05
66 Hypoxia and oxidative stress. Tumour hypoxia--therapeutic considerations. Breast Cancer Res 2001 1.02
67 Modulation of circulating angiogenic factors and tumor biology by aerobic training in breast cancer patients receiving neoadjuvant chemotherapy. Cancer Prev Res (Phila) 2013 0.99
68 Expression of HIF-1alpha in human tumours. J Clin Pathol 2005 0.97
69 Does the theory of planned behavior mediate the effects of an oncologist's recommendation to exercise in newly diagnosed breast cancer survivors? Results from a randomized controlled trial. Health Psychol 2005 0.97
70 Nitric oxide as a metabolic regulator during exercise: effects of training in health and disease. Clin Exp Pharmacol Physiol 2000 0.95
71 Hypoxia induced resistance to doxorubicin in prostate cancer cells is inhibited by low concentrations of glyceryl trinitrate. J Urol 2003 0.94
72 Exercise training enhances vasodilation responses to vascular endothelial growth factor in porcine coronary arterioles exposed to chronic coronary occlusion. Circulation 2004 0.91
73 Exercise delays allogeneic tumor growth and reduces intratumoral inflammation and vascularization. J Appl Physiol (1985) 2004 0.87
74 VEGF-D and HIF-1alpha in breast cancer. J Clin Pathol 2005 0.84
75 Effects of exercise training on vascular function and myocardial perfusion. Cardiol Clin 2001 0.83
76 Forearm vasoreactivity in type 1diabetic subjects. Can J Appl Physiol 2001 0.81
77 [Standards, Options and Recommendations for the management of ductal carcinoma in situ of the breast (DCIS): update 2004]. Bull Cancer 2005 0.79
78 Exercise and endothelial function. Circulation 2000 0.76
Next 100